It has become increasingly apparent using molecular techniques such as polymerase chain reaction (PCR) amplification of hepatitis B virus (HBV) and hepatitis C virus (HCV) genomes in serum or liver that low level persistent viral infection is a major problem in alcoholics with liver disease. There is recent evidence to suggest that chronic ethanol abuse in the setting of HBV and HCV infection promotes the deterioration of the liver disease and increases the risk for development of hepatocellular carcinoma. Thus, it is important to understand the effects of ethanol on the host cellular and humoral immune response to HBV and HCV that may allow for persistent viral infection to occur. This proposal will focus on molecular genetic techniques designed to induce a host immune response to viral structural proteins. We anticipate that such approaches may eventually be used to design antiviral agents that reduce or terminate viral replication in the liver and therefore have clinical applications for the alcoholic.
Our aims are as follows: (1) Explore the use of polynucleotide based immunization to generate humoral and cellular immune responses in mice to the highly conserved HCV core protein and study the effects of ethanol on antiviral immune responses. (2) Evaluate the effect of ethanol on cellular and humoral immune responses to HBV large (LBHs) and middle (MHBs) envelope and core proteins as generated by DNA immunization. (3) Study the antiviral effects of HBV dominate negative core mutant constructs used as """"""""intracellular immunogens"""""""" to inhibit HBV replication and examine the role of ethanol on intrahepatic viral gene expression in vivo. Indeed, it has not, heretofore, been possible to study cellular immune responses in vivo to HCV and HBV structural proteins with respect to any alcohol effects, since there was no method available to generate viral specific CTL activity in an animal model system. Our preliminary data suggests that polynucleotide based immunization will induce strong cellular immunity to HCV and HBV that may have antiviral activity. These investigations will allow us to assess ethanol effects on such cellular immune responses which will contribute to a better understanding of the pathogenesis of persistent viral infection in the alcoholic with liver disease.

Agency
National Institute of Health (NIH)
Institute
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Type
Research Project (R01)
Project #
5R01AA008169-08
Application #
2607592
Study Section
Special Emphasis Panel (ZRG4-ALTX-2 (01))
Project Start
1993-12-01
Project End
2001-11-30
Budget Start
1997-12-01
Budget End
1998-11-30
Support Year
8
Fiscal Year
1998
Total Cost
Indirect Cost
Name
Massachusetts General Hospital
Department
Type
DUNS #
City
Boston
State
MA
Country
United States
Zip Code
02199
Ortiz, Vivian; Wands, Jack R (2014) Chronic ethanol diet increases regulatory T-cell activity and inhibits hepatitis C virus core-specific cellular immune responses in mice. Hepatol Res 44:788-97
Derdak, Zoltan; Villegas, Kristine A; Harb, Ragheb et al. (2013) Inhibition of p53 attenuates steatosis and liver injury in a mouse model of non-alcoholic fatty liver disease. J Hepatol 58:785-91
de la Monte, Suzanne; Derdak, Zoltan; Wands, Jack R (2012) Alcohol, insulin resistance and the liver-brain axis. J Gastroenterol Hepatol 27 Suppl 2:33-41
Derdak, Zoltan; Lang, Charles H; Villegas, Kristine A et al. (2011) Activation of p53 enhances apoptosis and insulin resistance in a rat model of alcoholic liver disease. J Hepatol 54:164-72
Feng, Dechun; Eken, Ahmet; Ortiz, Vivian et al. (2011) Chronic alcohol-induced liver disease inhibits dendritic cell function. Liver Int 31:950-63
Eken, Ahmet; Ortiz, Vivian; Wands, Jack R (2011) Ethanol inhibits antigen presentation by dendritic cells. Clin Vaccine Immunol 18:1157-66
Qin, Yanli; Zhang, Jiming; Garcia, Tamako et al. (2011) Improved method for rapid and efficient determination of genome replication and protein expression of clinical hepatitis B virus isolates. J Clin Microbiol 49:1226-33
Qin, Yanli; Tang, Xiaoli; Garcia, Tamako et al. (2011) Hepatitis B virus genotype C isolates with wild-type core promoter sequence replicate less efficiently than genotype B isolates but possess higher virion secretion capacity. J Virol 85:10167-77
de la Monte, Suzanne M; Pang, Maoyin; Chaudhry, Rajeev et al. (2011) Peroxisome proliferator-activated receptor agonist treatment of alcohol-induced hepatic insulin resistance. Hepatol Res 41:386-98
von dem Bussche, Annette; Machida, Raiki; Li, Ke et al. (2010) Hepatitis C virus NS2 protein triggers endoplasmic reticulum stress and suppresses its own viral replication. J Hepatol 53:797-804

Showing the most recent 10 out of 63 publications